Navigation Links
Bionovo Announces Third Quarter 2010 Highlights and Financial Results
Date:11/11/2010

EMERYVILLE, Calif., Nov. 11, 2010 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced third quarter highlights and financial results for the three months ended September 30, 2010. The company also announced that it had positively concluded a key regulatory meeting with the U.S. Food and Drug Administration (FDA) and was proceeding with preparations for pivotal testing of Menerba, the company's drug candidate for menopausal hot flashes.

"We now have a clear path forward from the FDA and the EMA, with approved CMC packages and complete clinical development plans. We are moving forward with Menerba as expeditiously as possible," said Isaac Cohen, Bionovo's Chairman and Chief Executive Officer. "This gives us, and any potential partner, the last piece in the regulatory puzzle."

Over the past quarter, the company accomplished the following:Key Events To Date

  • The Company held an anticipated meeting with the U.S. Food and Drug Administration (FDA) on the clinical development plan for Menerba in the U.S. Earlier, the Company had a meeting with the FDA regarding Menerba's Chemistry, Manufacturing and Controls (CMC) package, wherein the FDA approved Menerba's CMC plan. "With agreements on both the clinical development and the CMC requirements, with both the FDA and the EMA, we are confident we can now satisfy the regulatory requirements for bringing Menerba to market," said Dr. Isaac Cohen.


  • The Company received notification that it had two projects approved for funding at the maximum level under the Qualifying Therapeutic Discovery Project Credit ("QTDP")  program.  Bionovo expects to receive the maximum level allowable under the program for its Menerba
    '/>"/>


  • SOURCE Bionovo, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Bionovo, Inc. to Announce Third Quarter Fiscal Year 2010 Financial Results on Thursday, November 11, 2010
    2. Bionovo Announces Publication Describing Potential Estrogen Receptor Modulating Drugs for Treating Menopausal Conditions
    3. Bionovo to Raise $3 Million Through Registered Direct Offering
    4. Bionovo to Present at the JMP Securities Healthcare Conference
    5. Bionovo to Present at Cambria Capital Investor Meeting
    6. Bionovo Receives Positive Guidance from FDA on Menerba®
    7. Bionovo Announces Reverse Stock Split
    8. Bionovo Announces Publication Describing Menerbas Effect on Neural Pathways Related to Temperature Regulation
    9. Bionovo to Advance Menerba to Phase 3 Clinical Testing in Europe
    10. Bionovo, Inc. to Announce Second Quarter Fiscal Year 2010 Financial Results on Wednesday, August 4, 2010
    11. Bionovo Announces a $15 Million At-The-Market Firm Commitment Financing Agreement
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/22/2014)... , Aug. 22, 2014  As the Medical Affairs, ... many leaders in this area are exploring methods to ... The Medical Affairs Consortium at Best Practices, LLC is ... sharing insights about the key challenges they face. The ... solutions through three virtual roundtable discussions where leaders discuss ...
    (Date:8/22/2014)... -- MC Medical, a subsidiary of Mitsubishi Corporation (MCM), and ... medical device company, have formally agreed to an ... system in Japan . It is anticipated ... Japan in the latter half of 2015. ... portfolio in endoscopic surgery market in Japan ...
    (Date:8/22/2014)... ., Aug. 22, 2014  Research presented at the 29 ... being developed by Hera Therapeutics Inc. combats three types of ... all cervical cancer. When tested in several cultured ... and HPV-11 cells, according to Louise T. Chow , ... findings at the Seattle conference. The ...
    Breaking Medicine Technology:Best Practices' Medical Affairs Consortium Survey Has Achieved Strong Participation 2MC Medical agrees to be the exclusive distributor of FloShield products in Japan 2Study shows Hera Therapeutics experimental compound shuts down human papillomavirus that causes most cervical cancer 2
    ... 26 Todd Bluedorn, chief executive officer of Lennox International ... at the J.P. Morgan HVAC Conference on Thursday, May 28 ... presentation materials can be accessed on the company,s website at ... archived for 60 days. The webcast can also be ...
    ... Health, Inc. (TH) is pleased to announce its involvement in ... Komen Foundation. TH,s collaborator, Duke University , was ... million of investment by the foundation in 2009 to further ... cancer.The Susan G. Komen for the Cure(R) is a nonprofit ...
    Cached Medicine Technology:Theranostics Health Announces Involvement with Major Academic Medical Center in Study Funded by Susan G. Komen for the Cure(R) 2Theranostics Health Announces Involvement with Major Academic Medical Center in Study Funded by Susan G. Komen for the Cure(R) 3
    (Date:8/22/2014)... 22, 2014 Natural Clear Vision , ... restore his own vision from legally blind to perfect 20/20 ... investigative review. , “There is a huge portion of ... everyday function, and most people just think that’s the way ... surgery that can be pretty risky at times,” reports Michaels. ...
    (Date:8/22/2014)... deletion in advanced non-small cell lung cancer (NSCLC) ... in epidermal growth factor receptor (EGFR) tyrosine kinase ... BIM deletion independently predicts overall survival (OS) of ... activate the programmed cell death also known as ... been detected in 12.8% of the Asian population ...
    (Date:8/22/2014)... Rheumatoid arthritis (RA), a complex autoimmune disease that ... patients to not only cope with pain, disability ... as disrupted work, family life and marital functioning. ... residual pain and disability is common. In addition, ... high cost or side effects. Because of this, ...
    (Date:8/22/2014)... London, UK (PRWEB) August 22, 2014 ... more magnetic for some clinical applications due to ... of the emerging innovations in ultrasound, such as ... imaging, are expected to keep the market moving ... as increasing mobility can enhance not only the ...
    (Date:8/22/2014)... Mueller Sports Medicine is excited to ... new product that provides non-drug instant relief for plantar ... you heal. The package includes 7 days of relief, ... – it is not kinesiology tape. It’s made in ... for Plantar Fasciitis is a breakthrough in the ...
    Breaking Medicine News(10 mins):Health News:Natural Clear Vision: Review Exposes Kevin Richardson’s Program for Restoring Vision Naturally 2Health News:Deletion predicts survival in advanced non-small cell lung cancer 2Health News:Study shows cognitive-behavioral coping skills training has positive effects on rheumatoid arthritis 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 3Health News:Mueller Introduces FasciaDerm® PFTape™ System for Plantar Fasciitis 2
    ... New York City has discovered that chronic pain occurs as ... colleagues were studying chronic pain at the molecular and cellular ... and the neurons becomes excited and begin to send signals ... the stimulus is removed the nerves become dormant and there ...
    ... mantids – that is, the female praying mantid eats ... possibility that males may also have something to gain ... In a paper in the August issue of The ... male risk-taking behavior in a praying mantis by altering ...
    ... facial transplant patient was discharged for a week after undergoing ... , ,Li Guoxing, 30, who had not seen his wife ... Xijing Hospital returned home Friday for a week-long visit to ... part of his face is alive and Li has been ...
    ... most common medical condition, chronic widespread pain is ... associated with fatigue, depression and poor sleep.// ... cancer patients deveolping FM like symptoms after treatment ... studies have shown contradictory results. A new study ...
    ... tested HIV positive was tied to his bedpost at the Meerut ... April after committing a robbery. He tested HIV positive only last ... College, which proved to be hopelessly inadequate to deal with his ... ago when a blood test confirmed he was HIV positive. He ...
    ... Alma Garcia, 41, were well aware of the toll ... was suffering from high blood pressure, diabetes and thyroid ... ,When they scheduled their gastric bypass surgeries at ... 2006, they joined a growing number of severely overweight ...
    Cached Medicine News:Health News:Insufficent Anti-inflammatoy Proteins Leads to Chronic Pain 2Health News:Weight-Loss Surgeries Changing Lives 2Health News:Weight-Loss Surgeries Changing Lives 3Health News:Weight-Loss Surgeries Changing Lives 4
    PosiBlot 30-30 Pads...
    ... VacuGene XL Vacuum Blotting System ... gels up to 20 30 ... Efficient and reproducible transfers improve blotting ... in the unit. Precise vacuum control ...
    ... Pens-Using a proprietary and patented technology, ADI ... called Antigen-Antibody pens-TM, that will allow researchers ... in any form or shape or size. ... to see antigen being written on the ...
    ... Advantages of using the Antigen-Antibody Pens-Using ... designed and developed specialized fountain pens, called ... deliver or write/mark the blotting membranes in ... specially formulated antigen-bonded colored dyes helps to ...
    Medicine Products: